Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

109.30 +3.21 (+3.03%)

Official Closing Price Updated: 7:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

52 53 Next >

Better Growth Stock: Abbott vs. AbbVie ↗

January 16, 2024

These healthcare giants also offer investors the promise of increasing passive income.

Via The Motley Fool

Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' ↗

January 12, 2024

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursda

Via Benzinga

3 Dividend Kings For Yield And Growth ↗

January 11, 2024

Dividend Kings are known for safe dividends and reliable long-term growth.

Via Talk Markets

$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

January 11, 2024

Via Benzinga

2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade ↗

January 11, 2024

Strong advantages over the competition could allow these businesses to keep raising their dividend payouts for at least another 10 years.

Via The Motley Fool

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

January 08, 2024

From Tandem Diabetes Care, Inc.

Via Business Wire

Beyond The Numbers: 5 Analysts Discuss Abbott Laboratories Stock ↗

January 03, 2024

Via Benzinga

Could Abbott Laboratories Stock Help You Become a Millionaire? ↗

January 03, 2024

There is a lot going the company's way, despite recent struggles.

Via The Motley Fool

3 Top Dividend Growth Stocks to Buy in 2024 ↗

January 02, 2024

Income investors should love these great stocks.

Via The Motley Fool

Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts ↗

December 28, 2023

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...

Via Benzinga

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population ↗

December 27, 2023

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Via InvestorPlace

Topics Economy

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

December 26, 2023

Via Benzinga

Where Abbott Laboratories Stands With Analysts ↗

December 13, 2023

Via Benzinga

$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today ↗

December 05, 2023

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

December 01, 2023

Via Benzinga

5 Top Stocks to Buy With Your End-of-the-Year Bonus ↗

December 23, 2023

Your bonus could become the gift that keeps on giving.

Via The Motley Fool

Better Growth Stock: AbbVie vs. Abbott Laboratories ↗

December 21, 2023

Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?

Via The Motley Fool

Dividend Income Update For November 2023 ↗

December 16, 2023

It’s dividend income update time. This is one of my favorite times of the month, as I get to review the previous month of passive income received from my dividend income portfolio.

Via Talk Markets

3 No-Brainer Healthcare Stocks to Buy Right Now ↗

December 15, 2023

These players have what it takes to boost your portfolio over time.

Via The Motley Fool

AbbVie continues shopping spree with biotech buyout

December 12, 2023

While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend.

Via MarketBeat

Spotlight on Abbott Laboratories: Analyzing the Surge in Options Activity ↗

November 30, 2023

Via Benzinga

2 Healthcare Stocks to Buy Hand Over Fist in December ↗

December 08, 2023

These stocks are great options now -- and most any month.

Via The Motley Fool

Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now. ↗

December 07, 2023

These particular players look cheap right now.

Via The Motley Fool

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

November 30, 2023

Via Benzinga

Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' ↗

November 30, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.

Via Benzinga

Medtronic: oversold, overextended high yield reversal in play

November 22, 2023

The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance

Via MarketBeat

Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration ↗

November 21, 2023

Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.

Via Benzinga

Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. ↗

November 20, 2023

New medicines for weight loss and diabetes stand to disrupt the competitive scene.

Via The Motley Fool

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

November 17, 2023

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

Via FinancialNewsMedia

3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing ↗

November 14, 2023

You'll be happy to own these top companies in any market environment.

Via The Motley Fool

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.